| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Arce Gallego, Sara |
| dc.contributor.author | Romero-Lozano, Paula |
| dc.contributor.author | Mir Arnau, Gisela |
| dc.contributor.author | Aguilar, Daniel |
| dc.contributor.author | Mast, Richard |
| dc.contributor.author | Cresta Morgado, Pablo |
| dc.contributor.author | Delgado-Serrano, Luisa |
| dc.contributor.author | Simonetti, Sara |
| dc.contributor.author | Macarena, Gonzalez |
| dc.contributor.author | Marmolejo Castañeda, David Humberto |
| dc.contributor.author | Morales-Barrera, Rafael |
| dc.contributor.author | Semidey Raven, Maria Eugenia |
| dc.contributor.author | Cordoba, Sarai |
| dc.contributor.author | de Albert de Delás-Vigo, Matias |
| dc.contributor.author | Planas, Jacques |
| dc.contributor.author | Cuadras Solé, Mercè |
| dc.contributor.author | Maldonado, Xavier |
| dc.contributor.author | Casanova-Salas, Irene |
| dc.contributor.author | Mas Malavila, Alba |
| dc.contributor.author | Nonell, Lara |
| dc.contributor.author | Dienstmann, Rodrigo |
| dc.contributor.author | Nuciforo, Paolo |
| dc.contributor.author | Vivancos, Ana |
| dc.contributor.author | Llop-Guevara, Alba |
| dc.contributor.author | Serra, Violeta |
| dc.contributor.author | Mateo, Joaquin |
| dc.contributor.author | Carles, Joan |
| dc.contributor.author | Suárez, Cristina |
| dc.date.accessioned | 2025-03-31T09:57:47Z |
| dc.date.available | 2025-03-31T09:57:47Z |
| dc.date.issued | 2025-02-18 |
| dc.identifier.citation | Arce-Gallego S, Cresta Morgado P, Delgado-Serrano L, Simonetti S, Gonzalez M, Romero-Lozano P, et al. Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence. Cell Reports Med. 2025 Feb 18;6(2):101937. |
| dc.identifier.issn | 2666-3791 |
| dc.identifier.uri | http://hdl.handle.net/11351/12845 |
| dc.description | Genómica; Inmunofluorescencia; Cáncer de próstata |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Cell Reports Medicine;6(2) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Anomalies cromosòmiques |
| dc.subject | Pròstata - Càncer - Aspectes genètics |
| dc.subject | Seqüència de nucleòtids |
| dc.subject | Metàstasi |
| dc.subject | ADN - Reparació |
| dc.subject.mesh | Mutation |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.subject.mesh | Prostatic Neoplasms |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Recombinational DNA Repair |
| dc.subject.mesh | High-Throughput Nucleotide Sequencing |
| dc.title | Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.xcrm.2025.101937 |
| dc.subject.decs | mutación |
| dc.subject.decs | metástasis neoplásica |
| dc.subject.decs | neoplasias de la próstata |
| dc.subject.decs | /genética |
| dc.subject.decs | reparación del ADN por recombinación |
| dc.subject.decs | secuenciación de nucleótidos de alto rendimiento |
| dc.relation.publishversion | https://doi.org/10.1016/j.xcrm.2025.101937 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Arce-Gallego S, Delgado-Serrano L, Mir Arnau G, Aguilar D, Cordoba-Terreros S, Casanova-Salas I] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cresta Morgado P] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Simonetti S, Nuciforo P] Molecular Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Gonzalez M, Marmolejo D, Morales-Barrera R, Suarez C, Carles J, Mateo J] Prostate Cancer Research, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Romero-Lozano P, Vivancos A] Cancer Genomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Semidey ME] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mast R, de Albert M] Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Planas J, Cuadras M] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Maldonado X] Servei d’Oncologia Radioteràpica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mas A, Nonell L] Bioinformatics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Dienstmann R] Oncology Data Science (OdysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. University of Vic - Central University of Catalonia, Vic, Spain. [Llop-Guevara A, Serra V] Experimental Therapeutics, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| dc.identifier.pmid | 39914385 |
| dc.identifier.wos | 001433264900001 |
| dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/FI19%2F00280 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |